Strong Performance in Canada Medical Business
The Canada medical business grew sales by 13% year-over-year, benefiting from a shift towards insurer patients and a larger product assortment in the Spectrum online store.
Restructuring and Cost Reduction
Canopy Growth has restructured its operations to improve synchronization and reduce costs, identifying at least $20 million in annual operating expense reductions over the next 12 to 18 months.
Improvement in Adjusted EBITDA
There was a year-over-year improvement in adjusted EBITDA, despite missing the target of positive adjusted EBITDA for fiscal 2025.
Positive Early Signs from Product Innovations
New products such as Claybourne infused pre-rolls and Tweed and 7ACRES all-in-one vapes have shown positive early consumer response, with encouraging market share growth.